U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Wednesday.Shares of Alibaba Group Holding Limited BABA rose sharply in pre-market trading.Alibaba is deepening its artificial intelligence ambitions by integrating Nvidia's NVDA suite of "physical AI" development tools into its cloud platform, a move that strengthens ties between two of the most influential players in global AI..Alibaba shares surged 9.3% to $178.21 in pre-market trading.Here are some other stocks mo ...

Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the Best Performing Long Term Stocks According to Analysts. On September 10, Avidity Biosciences, Inc. (NASDAQ:RNA) announced positive one-year data for its, del-zota, in the EXPLORE44 and EXPLORE44-OLE trials for Duchenne muscular dystrophy patients amenable to exon 44 skipping. Management noted that the data show a reversal of disease progression and significant functional improvements compared to baseline and natural history. Del-zota works by delivering ...

CARBIOS has reduced its operating expenses and has a strong cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 monthsThe Longlaville plant construction project is now supported by: Major progress with public financers ADEME and the Regional CouncilClear interest from private investors, conditional upon the pre-sale of a significant portion of the future plant’s capacity, which has not yet been achievedRecent regulatory developments that enhance the competitiveness ...

Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share CapitalClarification in Response to Unfounded Accusations NANTES, France – September 24, 2025, 8:00 a.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) corrects the information relating to the total number of shares and voting rights comprising its share capital. As part of the preparation for the General Meeting on September 30, 2025, OSE identified a processing error related to t ...

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), of the important November 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Savara securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO ...

In this piece, we discuss the 10 Best Debt Free Small Cap Stocks to Buy Now.High leverage can be both an advantage and a liability. While on one hand, borrowing may reduce taxable income and increase returns in good times, on the other hand, it can also create fixed obligations that linger when profits shrink.For small-cap companies, which are often characterized by uneven cash flows, high leverage can quickly turn into a liability. On the other hand, debt-free or low-debt companies enjoy the flexibility to ...

In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Tiziana Life Sciences Ltd is one of them. Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a clinical-stage biotech company focused on next-generation immunomodulation therapies for neuroinflammatory and neurodegenerative diseases, including multiple sclerosis, Alzheimer’s, and multiple system atrophy. Its lead candidate, intranasal foralumab, is a fully human anti-CD3 monoclonal antibody designed to stimulate ...

In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. MindWalk Holdings Corp. stands third among them. MindWalk Holdings Corp. (NASDAQ:HYFT), formerly ImmunoPrecise Antibodies, is a Bio-Native AI company combining artificial intelligence, multi-omics data, and biologics research to accelerate drug discovery. Its proprietary LensAI™ platform and HYFT technology support pharmaceutical and biotech partners in de-risking development and advancing new therapeutic ...

In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. I-Mab stands second among them. I-Mab (NASDAQ:IMAB) is a U.S.-based biotechnology company focused on precision immuno-oncology, developing differentiated therapies for cancer. Its lead candidate, givastomig, is a bispecific antibody targeting Claudin 18.2 and 4-1BB, designed to selectively activate T cells within the tumor microenvironment, aiming to maximize anti-tumor effects while reducing common toxic ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...